Category: News

News

  • Le CN fait état du transport de céréales au troisième trimestre

    MONTRÉAL, 06 oct. 2026 (GLOBE NEWSWIRE) — Le CN (TSX : CNR) (NYSE : CNI) a annoncé aujourd’hui avoir établi un nouveau record trimestriel de transport de céréales. Le CN a transporté 7,94 millions de tonnes métriques (MTM) de céréales de l’Ouest canadien au troisième trimestre, surpassant le précédent record de 7,48 MTM établi en 2020.

    Originally published via Source Article.

  • The MicDrop Agency Expands AEC Technology Practice into Europe with Groundworks 2026 Appointment

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Originally published via Source Article.

  • The MicDrop Agency Expands AEC Technology Practice into Europe with Groundworks 2026 Appointment

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Originally published via Source Article.

  • The MicDrop Agency Expands AEC Technology Practice into Europe with Groundworks 2026 Appointment

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Originally published via Source Article.

  • The MicDrop Agency Expands AEC Technology Practice into Europe with Groundworks 2026 Appointment

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Originally published via Source Article.

  • The MicDrop Agency Expands AEC Technology Practice into Europe with Groundworks 2026 Appointment

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Named official PR agency of record for the inaugural London construction robotics summit, MicDrop builds on its established North American AEC portfolio

    Originally published via Source Article.

  • Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context

    AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

    Originally published via Source Article.

  • Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context

    AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

    Originally published via Source Article.

  • Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context

    AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

    Originally published via Source Article.

  • Drug Discovery Informatics Market Projected to Reach $7.74 Billion by 2030 as AI Agents Need Biological Context

    AUSTIN, Texas, Oct. 06, 2026 (GLOBE NEWSWIRE) — Equity Insider News Commentary – The global market for artificial intelligence in drug discovery is projected to grow from $5.09 billion in 2026 to $17.56 billion by 2031, a compound annual growth rate of 28.1%, according to MarketsandMarkets. As that spending moves from pilots into discovery workflows, the enterprise software industry has converged on a new layer between an organization’s data and the AI agents that act on it, variously called an ontology, a semantic layer or a context layer. The open question for life sciences is whether a layer built to describe a business can also describe biology. Active Companies from around the markets with current developments this week include: MindWalk Holdings Corp. (NASDAQ: HYFT), Palantir Technologies Inc. (NASDAQ: PLTR), Snowflake Inc. (NYSE: SNOW), Microsoft Corporation (NASDAQ: MSFT), Veeva Systems Inc. (NYSE: VEEV).

    Originally published via Source Article.